What Cambrooke Therapeutics does

Cambrooke Therapeutics (legally Ajinomoto Cambrooke, Inc.) is a US-based specialty medical nutrition company founded in 2000 by Lynn and David Paolella in Natick, Massachusetts, now headquartered in Ayer, MA. The company develops, manufactures, and commercializes medical foods and nutritional therapies for patients with inborn errors of metabolism — primarily phenylketonuria (PKU), tyrosinemia (TYR), homocystinuria (HCU), maple syrup urine disease (MSUD), isovaleric acidemia (IVA), and intractable epilepsy — as well as low-protein specialty foods for related dietary conditions.

The company's core technological differentiator is its proprietary glycomacropeptide (GMP)-based platform, commercialized under the Glytactin brand for PKU and Tylactin for tyrosinemia. GMP is a naturally occurring low-phenylalanine whole protein derived from whey through a cheese-making process, combined with large neutral amino acids (LNAAs). The company claims this formulation stabilizes phenylalanine levels throughout the day, reduces Phe absorption across the blood-brain barrier, and normalizes ghrelin (hunger hormone) levels. The broader product portfolio includes amino acid formulas (Homactin AA Plus, Vilactin AA Plus, Isovactin AA Plus), the KetoVie ketogenic formula line for intractable epilepsy, KetoVie Café ready-to-eat ketogenic foods, an extensive low-protein specialty food catalog, and ENU Nutrition shakes. In December 2025, the company launched DreamCap, a new user-friendly closure system compatible with the BoLink feeding platform.

The business operates a direct-to-consumer e-commerce model (shop.cambrooke.com and a separate Canadian storefront) supplemented by a healthcare professional channel with Salesforce-powered sample requests, clinical training, and reimbursement support. Medical formulas are reimbursed via HCPCS codes B4157 and B4162. Products are sold on a one-time purchase basis with unit and case pricing tiers (e.g., KetoVie Café Cinnamon Donut Delights at $15.99 single / $79.69 case). Since 2017, Cambrooke has operated as a wholly-owned subsidiary of Japanese food and biotechnology conglomerate Ajinomoto Co., Inc., which has supported international expansion into the UK, Germany, Canada, and Australia.

Name

Cambrooke Therapeutics

Legal name

Ajinomoto Cambrooke, Inc.

Website

https://cambrooke.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Cambrooke Therapeutics, a wholly-owned Ajinomoto subsidiary, develops and sells GMP-based medical foods (Glytactin, Tylactin, KetoVie) and low-protein specialty foods for patients with rare inborn errors of metabolism including PKU, tyrosinemia, MSUD, HCU, and intractable epilepsy, primarily through direct-to-consumer e-commerce and healthcare provider channels across the US, Canada, UK, Germany, and Australia.

Ownership category

akta.pro rank

Product category

Specialty Medical Nutrition

NAICS

Food Manufacturing (311), Food (Health) Supplement Retailers (456191)

SIC

Miscellaneous Food Preparations & Kindred Products (2090), Food And Kindred Products (2000)

akta.pro primary industry

Medical Nutrition & Meal Replacement (RTD, Bars, Powders) (CRADAGAN)

akta.pro secondary industries

Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium) (AFAKAJAD), Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic) (CRADAEAB), Better-for-You / Functional Snacks (Low Sugar, Keto, Probiotic, Fortified) (CRADABAM)

Keywords

• Medical nutrition products
• Therapeutic medical foods
• Metabolic disorder formulas
• Low protein specialty foods
• Ketogenic medical formulas

Headquarters

HQ city

Ayer

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Formula Products: Cambrooke generates revenue through direct sales of medical nutrition formulas including Glytactin (PKU), Tylactin (TYR), amino acid formulas (HCU, MSUD, IVA), and KetoVie ketogenic products. Products are sold as one-time purchases through e-commerce with case and single-unit pricing options. Healthcare providers and insurance reimbursement (HCPCS codes B4157, B4162) also facilitate product access.
2. Low Protein Specialty Foods: Direct-to-consumer sales of low protein specialty foods including breads, baked goods, pasta, meat alternatives, snacks, and prepared meals through their online store. Products are sold in single units and cases with prices ranging from approximately $8 to $60 per item.
3. Ketogenic Foods (KetoVie Café): Sales of ready-to-use ketogenic foods including Cinnamon Donut Delights, Creamy Cereal, Kwik Mix, Pizza Petites, and Wholesome Bread. Products sold through e-commerce with single and case pricing.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Cambrooke Therapeutics develops, manufactures, and sells medical nutrition formulas and specialty foods for patients with inborn errors of metabolism (PKU, Tyrosinemia, MSUD, HCU, IVA), intractable epilepsy, and severe protein allergies. Its core products include GMP-based Glytactin and Tylactin medical formulas, Amino Acid Plus formulas, KetoVie ketogenic formulas and KetoVie Café ready-to-eat ketogenic foods, low-protein specialty foods, ENU nutritional shakes, and pediatric formulas (Essential Care Jr., EquaCare Jr.). Products are sold directly to patients and caregivers via e-commerce and through healthcare professionals, with reimbursement available under HCPCS codes B4157 and B4162.

Differentiator

Problem solved

Functional benefit

Brands

• Glytactin: Glycomacropeptide (GMP) based medical food for the dietary management of Phenylketonuria (PKU). Includes products like RTD, BUILD, COMPLETE, RESTORE, and BetterMilk.
• Tylactin
• KetoVie
• KetoVie Café
• ENU Nutrition
• Essential Care Jr.
• EquaCare Jr.
• Homactin AA Plus
• Vilactin AA Plus
• Glytactin eLearning Tool
• CAMBROOKEcare

Products and services

• Glytactin (PKU Medical Formulas) Glycomacropeptide (GMP)-based medical food product line for the dietary management of Phenylketonuria (PKU). Includes RTD, BUILD, COMPLETE, RESTORE Powder, RESTORE Lite Powder, RTD Lite, BetterMilk, SWIRL, and REFRESH formats. Glytactin is the first and only naturally occurring low-phenylalanine whole protein for PKU, stabilized with essential LNAAs to manage blood Phe levels throughout the day.
• Tylactin (Tyrosinemia Medical Formulas) Glycomacropeptide (GMP)-based medical food line for the dietary management of Hereditary Tyrosinemia (TYR). Includes RTD, BUILD, COMPLETE, RESTORE Powder, and REFRESH formats. Utilizes the same GMP technology platform adapted for tyrosine and phenylalanine-restricted diets as an effective alternative to traditional amino acid formulas.
• KetoVie (Ketogenic Medical Formulas) Ketogenic formula products for the dietary management of patients with intractable epilepsy. Includes KetoVie 4:1, KetoVie Peptide 4:1, and KetoVie 3:1 ratio formulas for use in medically supervised ketogenic diet therapy.
• KetoVie Café (Ready-to-Eat Ketogenic Foods) Low-carbohydrate ketogenic friendly foods for individuals following ketogenic diets, including Cinnamon Donut Delights, Creamy Cereal, Kwik Mix, Pizza Petites, Raspberry Muffins, and Wholesome Bread. Sold in single units and cases priced from $15.99 to $54.25 single / $79.69 to $332.41 case.
• Amino Acid Plus Formulas (Homactin AA Plus, Vilactin AA Plus, Isovactin AA Plus) Ready-to-drink nutritionally complete amino acid formulas for Homocystinuria (HCU), Maple Syrup Urine Disease (MSUD), and Isovaleric Acidemia (IVA). Enhanced with a bone-health blend including Vitamin D (620 IU/g PE), Calcium (677 mg), Phosphorus (664 mg), Zinc, Magnesium, Vitamin K1/K2 MK-7, Inulin, essential fats, DHA, and pre-biotic fiber. OU-D Kosher certified.
• Low Protein Specialty Foods Direct-to-consumer low-protein specialty foods including breads, baked goods, pasta, meat alternatives, snacks, ready meals, sauces, soups, baby foods, and prepared meals for patients with diet-managed metabolic disorders. Sold through the Cambrooke shop in single units and cases priced approximately $8 to $60 per item. Categories include baking, breads, breakfast, cheese, chocolates, desserts, fresh filled pasta, meat alternatives, ready meals, rice and pasta, sauces, sides, snacks, soups and seasonings, and spreads.
• ENU Nutritional Shakes Nutritional shakes for malnutrition support and nutritional supplementation, marketed under the ENU Nutrition brand. Designed for patients needing complete nutritional support, convenient ready-to-drink options for weight management and malnutrition.
• Essential Care Jr. and EquaCare Jr. Medical nutrition formulas for children with protein-related conditions. Includes Essential Care Jr. Ready-To-Drink formula and EquaCare Jr. medical nutrition product, marketed for children managing severe protein allergies and other protein-related medical conditions.
• Cambrooke Canadian Store Separate Canadian e-commerce storefront at store.nexternal.com/cbfi2002 enabling direct-to-consumer sales of Cambrooke medical formulas, low-protein foods, and ketogenic products to Canadian customers.

Quantifiable outcome

• Glytactin stabilizes Phe levels throughout the day, eliminating the spikes and troughs seen with alternative PKU preparations, leading to increased energy levels and improved concentration
• +3 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• University of Wisconsin, MadisoncoreStrategic or Co-development PartnerGroundbreaking collaboration with scientists at the University of Wisconsin, Madison resulted in the development of Glytactin with glycomacropeptide (GMP), an innovative protein source derived from whey. This partnership created the world's first GMP-based product for PKU dietary management.
• New England Connection for PKU and Allied Disorders (NECPAD)minorStrategic or Co-development PartnerLynn Paolella, co-founder of Cambrooke, was a founding member of NECPAD alongside dedicated mothers and clinicians. David Paolella remained a steadfast supporter and contributor to the organization's mission and events.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Nutricia: Global medical nutrition division of Danone specializing in metabolic and disease-specific formulas including PKU, MSUD, and other inborn errors of metabolism — Cambrooke's most direct large-scale competitor across medical formulas and low-protein foods.
• Vitaflo: Specialist medical nutrition company (within Nestlé Health Science) focused on inherited metabolic disorders, ketogenic diets, and pediatric nutrition — directly comparable niche footprint and product set to Cambrooke.
• Solace Nutrition: Specialty medical nutrition company producing formulas and foods for inborn errors of metabolism including PKU, MSUD, and other amino acid disorders; competes with Cambrooke across the same metabolic condition set.
• ENU Nutrition: Cambrooke's own sub-brand providing nutritional shakes for malnutrition and weight management; listed separately here to flag the internal brand-level peer that competes with third-party medical nutrition shakes in the malnutrition support category.

Broad incumbents

• Mead Johnson Nutrition: Established medical and infant nutrition brand (Reckitt Benckiser subsidiary) offering metabolic and specialty formulas; competes with Cambrooke in core medical nutrition categories through broader institutional and retail channels.
• Abbott Nutrition: Major global medical nutrition manufacturer offering disease-specific formulas including metabolic products; competes with Cambrooke in medical foods and pediatric/specialty nutrition.
• Nestlé Health Science: Global medical nutrition business within Nestlé covering rare metabolic disorders, ketogenic diets (Vitaflo brand), and pediatric nutrition; significant overlap with Cambrooke across multiple metabolic franchises.

Emerging players

• BioMarin Pharmaceutical: Developer of pegvaliase-pqpz and other enzyme and gene therapies for PKU; represents a therapeutic alternative rather than a direct nutrition competitor, but its success would displace medical-food demand for Cambrooke's PKU franchise.
• Taranis Medical Nutrition: Niche medical nutrition player providing amino acid-based formulas for rare metabolic conditions; smaller-scale but directly competitive in the same orphan-disease specialty nutrition category as Cambrooke.

Others

• Galen Partners: Healthcare-focused growth equity investor; led a prior Cambrooke funding round and remains a known capital partner and comparable touchpoint for specialty medical nutrition investing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/c/AjinomotoCambrooke
• Facebookfacebook.com/137183219671698
• Xx.com/CambrookeFoods
• LinkedInlinkedin.com/company/cambrooke-therapeutics

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambrooke Therapeutics